Intelligence Platform

Patents

Browse 750 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 10781251

Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)

Julius-Maximilians-Universitat Wurzburg · Granted Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10772942

Lyophilized factor IX formulations

BIOVERATIV THERAPEUTICS INC. · Granted Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10772906

Modulation of Factor 11 expression

Ionis Pharmaceuticals, Inc. · Granted Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10745680

Factor IX fusion proteins and methods of making and using same

BIOVERATIV THERAPEUTICS INC. · Granted Tue Aug 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10736875

Methods and compositions associated with the granulocyte colony-stimulating factor recepto

Ligand Pharmaceuticals Incorporated · Granted Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10709799

Activatable antibodies that bind epidermal growth factor receptor and methods of use there

CytomX Therapeutics, Inc. · Granted Tue Jul 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10703797

Gene therapy vectors for treatment of Danon disease

Rocket Pharmaceuticals, Ltd. · Granted Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10696945

Methods for treating a brain tissue damage by cultured adult pluripotent olfactory stem ce

China Medical University · Granted Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10682416

Epicardial-derived paracrine factors for repairing cardiac tissue

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10682393

Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and con

United States Department of Veteran Affairs · Granted Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10676537

Antibody targeted to tissue factor, preparation method therefor, and use thereof

SHANGHAI MIRACOGEN INC. · Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10668129

Synergistic combination of neuronal viability factors and uses thereof

The Regents of the University of California · Granted Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10668049

Methods of treating cognitive decline with transforming growth factor beta inhibitors

The Regents of the University of California · Granted Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10662440

Self-limiting viral vectors encoding nucleases

Precision BioSciences, Inc. · Granted Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10660918

Method for enhancing insulin like growth factor 1 receptor expression of mesenchymal stem

China Medical University · Granted Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10662183

Inhibitors of myocardin-related transcription factor and serum response factor (MRTF/SRF)-

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10646588

RP2 and RPGR vectors for treating X-linked retinitis pigmentosa

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10619153

TAL effector-mediated DNA modification

Regents of the University of Minnesota · Granted Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10603275

Clotting factor preparations for delivery into tissue of the intestinal tract using a swal

Rani Therapeutics, LLC · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10604565

Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof f

Julius-Maximilians-Universitat Wurzburg · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10604548

Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10596247

Methods and compositions for attenuated chlamydia as vaccine and vector

The Board of Regents of the University of Texas System · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10588949

Factor IX polypeptide formulations

BIOVERATIV THERAPEUTICS INC. · Granted Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10584356

Multigenome retroviral vector preparations and methods and systems for producing and using

IMMUNE DESIGN CORP. · Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted